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Tuesday, February 18, 2014 599areconstruction quality, CS reconstructions were compared with weighted back-
projections of two classes of phantom: (1) derived from experimental data, and
(2) derived from a generative model that approximates the structure of
membrane-bound organelles. We are investigating the application of the CS
approach for decreasing acquisition times and electron dose, and for improving
the reconstruction quality of electron tomograms recorded from micrometer-
thick specimens of neuronal tissues in the scanning transmission electron
microscope.
This work was supported in part by the Intramural Research Program of
NIBIB, NIH.
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Human factor VIII (FVIII) is a multidomain-plasma glycoprotein critical for
blood coagulation which when activated (FVIIIa) functions as a co-factor to
the serine protease factor IXa (FIXa) within the membrane-bound tenase
complex. We have developed single bilayer lipid nanotubes (LNT) resem-
bling by dimensions and lipid composition the activated platelet pseudo-
podia holding the tenase complex in vivo. We have successfully organized
helically recombinant FVIII on LNT and calculate the membrane-bound
structure at resolution sufficient to resolve its membrane-bund domain
organization.
In this work, we present the macromolecular organization of human FVIII
helically organized on LNT, as resolved by Cryo-electron microscopy at inter-
mediate resolution (10 - 15 A˚) which we compare to the porcine FVIII
membrane-bound structure from helical assemblies on LNT at the same exper-
imental conditions. We compare these structures to the FVIII structures when
organized in 2D and 3D crystals and when attached to lipid nanodisks (ND), to
define the conformational space and flexibility of this important for blood coag-
ulation macromolecule.
Our goal is to identify the FVIII protein-protein and protein-lipid interfaces
critical for the tenase complex assembly and function.
This work is supported by a National Scientist Development grant from the
American Heart Association: 10SDG3500034 and UTMB-NCB startup funds
to SSM. SSM acknowledge the staff of the Cryo-EM facility, the scientific
computing facility and the director of the Sealy Center for Structural biology
at UTMB (www.scsb.utmb.edu) Dr. Monte Pettitt.
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A new frontier exists in unraveling interactive biological and biochemical pro-
cesses and pathways at the macromolecular level. Of critical importance is the
three-dimensional visualization of protein complexes and molecular machines
in their native functional state. Three techniques play a major role in orches-
trating this.
Nuclear magnetic resonance (NMR) has the capability to study specific protein
domains or fragments and their role in protein folding and dynamics and in
ligand binding. X-Ray crystallography (XRD) provides high-resolution but
more static 3D structures of apo and liganded proteins, mainly in a monomeric
or dimeric state after crystallization. To unravel more physiologically relevant
situations, it is essential to visualize multimeric complexes in their tertiary and
quaternary state and their interaction with other complexes. By performing
cryo-transmission electron microscopy (cryo-TEM) applications like single
particle analysis or tomography, this can be achieved. Cryo-TEM provides
complementary information to NMR and XRD that can be crucial for under-
standing the structure of protein complexes that when combined can help
answer real biological as well as medically relevant questions.
Recent developments in cryo-TEM have brought the three major structural
biology technologies closer together. When combined with molecular dy-
namics simulations, a continuum has been reached on all important aspects
with regards to resolution and macromolecular scales which allows for full
deployment of the combination of these technologies.
Here, we will illustrate the historical context of these technologies with respect
to one another and show how recent developments have reached the critical re-
quirements needed to fully unleash the power of structural biology for not just
answering fundamental questions, but actually contributing to curing diseases
and improving health. We will discuss the future of structural biology based
on results from recent publications and expected developments over the next
several years.3027-Pos Board B719
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In cryo-electron microscopy of vitreously frozen biological specimens,
phase-plate imaging can greatly increase the signal-to-noise ratio of the mi-
crographs. When routinely used, this imaging technique may be the method
of choice for cryo-electron tomography, in which each image in the
tilt-series data set suffers from a high noise background due to the low-
electron-dose exposure. Utilizing the Zernike phase-contrast imaging tech-
nique, we have carried out an electron tomographic study of the axonemal
microtubule doublets and their associated radial spokes. The reconstructed
tomogram displays a strong contrast. The quality of the resultant density
maps, obtained by sub-volume averaging of a single tomogram in this study,
is comparable with that from the averaging of many cryo-tomograms without
using the phase-plate.
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An emerging strategy for solving medium-resolution (5-10 A˚) structures
entails complexing the protein of interest with monoclonal antibodies and
solving the complex by single particle transmission electron microscopy
(TEM.) The addition of Fabs to target molecules is an attractive strategy
because it increases the mass of the complex (improving its resolvability
by single-particle TEM), adds a fiducial marker that aids the interpretation
of the resulting volume maps, and potentially elucidates an immunological
site of interest. We note a possible limitation to this approach owing to the
localization of the Fabs in the resulting complex. Alignment parameters
that optimize the Fab constant domains’ convergence may come at the
expense of the visualization of the core particle of interest. We evaluate
the implications of this conjecture with respect to both experimental and syn-
thetic data.
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Activated Factor VIII (FVIIIa) is the essential co-factor for the serine protease
Factor IXa (FIXa) in the membrane-bound Tenase complex. In the blood coag-
ulation process, the interaction between FVIIIa and FIXa in presence of Ca2þ
and phospholipids amplifies the proteolytic activity of Factor IXa more than
100.000 times. The Tenase complex catalyzes the activation of Factor X and
initiates a cascade of multi-protein complex formation which amplifies the
Thrombin production and secures the formation of a blood clot.
Here we report for the first time the 3D-structure of the membrane-bound
FVIIIa form, which is the most physiologically relevant in relation to the deli-
cate equilibrium of hemostasis and thrombosis.
The structure of the membrane bound light chain (domains A3-C1-C2) of hu-
man FVIII helically organized onto lipid bilayer nanotubes (LNT) clarified that
the domains adopt a different organization than in the crystal structure which
represents the molecule in solution. These differences of the membrane-
bound FVIII structure have to be confirmed for the full length FVIII protein
and the active form. To achieve this, high resolution Cryo-EM data of porcine
FVIII and FVIIIa helically organized on LNT at closest to physiological con-
ditions were collected. A newly developed process of iterated rounds of 2D
refinement was applied to select only highly organized homogenous helical
segments for an effective iterative helical real-space reconstruction (IHRSR).
The calculated porcine FVIII and FVIIIa membrane-bound structures at sub-
nanometer resolution were combined with flexible docking to define the
changes in the FVIIIa interfaces important for its function.
Understanding the structural differences and similarities between the
membrane-bound activated FVIII and the non-activated FVIII will make an
indispensable contribution to the field of coagulation in determining unique tar-
gets for the design of specific therapeutic drugs against Hemophilia A and
thrombosis.
